Chemistry, Department of: Faculty Series

 

Andrzej Rajca Publications

Accessibility Remediation

If you are unable to use this item in its current form due to accessibility barriers, you may request remediation through our remediation request form.

Document Type

Article

Date of this Version

2012

Citation

J Am Chem Soc. 2012 September 26; 134(38): 15724–15727.

Comments

Copyright 2012 Am Chemical Soc. Used by permission.

Abstract

We report a molecular design that provides an intravenously injectable organic radical contrast

agent (ORCA) that has molecular r1 ≈ 5 mM−1s−1. The ORCA is based on spirocyclohexyl

nitroxide radicals and polyethylene glycol chains conjugated to a generation 4 polypropylenimine

dendrimers scaffold. The metal-free ORCA has a long shelf-life and provides selectively enhanced

MRI in mice for over 1 h.

Share

COinS